Literature DB >> 17151300

Differences in expression of cardiovascular risk factors among type 2 diabetes mellitus patients of different age.

Christos Kalofoutis1, Christina Piperi, Aikaterini Zisaki, Jaipaul Singh, Fred Harris, David Phoenix, Antonis Alaveras, Anastasios Kalofoutis.   

Abstract

Atherosclerotic coronary heart disease and other forms of cardiovascular disease (CVD) are the major cause of mortality in type II diabetes (T2DM) as well as a major contributor to morbidity and lifetime costs. The purpose of this article is the identification of the biochemical parameters in plasma, which may serve as predisposition factors to CVD in T2DM patients of different ages. The variability of hyperglycemia, dyslipidemia, and inflammation with age progression was also studied for comparison. Four different diabetic groups allocated on the basis of the subjects' age (Group A: 15-25 years old; Group B: 26-40 years old; Group C: 40-60 years old; Group D: 60-80 years old) and consisting of 10 patients each, in parallel with 10 healthy controls matched for age, sex, and ethnic origin were screened for glucose, insulin, lipid profile (total cholesterol, triglycerides, LDL, and HDL), and inflammatory mediators (CRP, IL-6, and TNF-alpha). Significant differences were observed among the expressions of biochemical markers among different age groups. Hyperglycemia showed no variability with age whereas dyslipidemia correlated positively with age progression, as well as obesity, low physical activity, and family history of heart disease or diabetes. Marked inflammation was prominent only in Groups C and D. This article indicates that different biochemical parameters may be used for the assessment of CVD risk in T2DM patients of variable age.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151300     DOI: 10.1196/annals.1372.001

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics.

Authors:  Michal Schnaider Beeri; Ramit Ravona-Springer; Erin Moshier; James Schmeidler; James Godbold; Tomas Karpati; Derek Leroith; Keren Koifman; Efrat Kravitz; Rachel Price; Hadas Hoffman; Jeremy M Silverman; Anthony Heymann
Journal:  Alzheimers Dement       Date:  2014-08-20       Impact factor: 21.566

Review 2.  Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Authors:  Iciar Martín-Timón; Cristina Sevillano-Collantes; Amparo Segura-Galindo; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2014-08-15

3.  The bigger, the stronger? Insights from muscle architecture and nervous characteristics in obese adolescent girls.

Authors:  S Garcia-Vicencio; E Coudeyre; V Kluka; C Cardenoux; A-G Jegu; A-V Fourot; S Ratel; V Martin
Journal:  Int J Obes (Lond)       Date:  2015-08-19       Impact factor: 5.095

4.  Glycosylated Haemoglobin (HbA1c) - A Marker of Circulating Lipids in Type 2 Diabetic Patients.

Authors:  Prabhavathi K; Kirthana Kunikullaya U; Jaisri Goturu
Journal:  J Clin Diagn Res       Date:  2014-02-03

5.  Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-alpha both in vitro and in vivo systems.

Authors:  Evros K Vassiliou; Andres Gonzalez; Carlos Garcia; James H Tadros; Goutam Chakraborty; Jeffrey H Toney
Journal:  Lipids Health Dis       Date:  2009-06-26       Impact factor: 3.876

Review 6.  The effects of cardiovascular risk factors on cognitive compromise.

Authors:  Michal Schnaider Beeri; Ramit Ravona-Springer; Jeremy M Silverman; Vahram Haroutunian
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

Review 7.  Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease.

Authors:  Kjeld Hermansen; Lene Sundahl Mortensen; Marie-Louise Hermansen
Journal:  Vasc Health Risk Manag       Date:  2008

Review 8.  Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system.

Authors:  Li Wang; Lijun Di; Constance Tom Noguchi
Journal:  Int J Biol Sci       Date:  2014-08-23       Impact factor: 6.580

Review 9.  Management of Inpatient Hyperglycemia and Diabetes in Older Adults.

Authors:  Guillermo E Umpierrez; Francisco J Pasquel
Journal:  Diabetes Care       Date:  2017-04       Impact factor: 17.152

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.